SCHEMBL7401096

SCHEMBL7401096

Cc1c(N)n[nH]c1OC(=O)O

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.31
AKT2 P31751 1/20 0.31
KMT2A Q03164 1/20 0.31
HCAR3 P49019 1/20 0.31
IKBKB O14920 1/20 0.30
HTT P42858 1/20 0.30
MAPK10 P53779 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3949819 0.69 HCAR2 (0.40) HCAR2
SCHEMBL2313410 0.68
SCHEMBL9038005 0.65 KDM4C (0.50) HTTMAPK10SMN1; SMN2
SCHEMBL24893847 0.64 TYMP (0.38) AKT2KMT2AIKBKB
SCHEMBL11526298 0.64 LMNA (0.33)
SCHEMBL10919362 0.63 GDA (0.47)
SCHEMBL7778263 0.63 HCAR2 (0.35) HCAR2HCAR3
SCHEMBL376808 0.63 HSP90AA1 (0.32)
SCHEMBL3953940 0.62 HCAR2 (0.41) HCAR2
SCHEMBL600381 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202988-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2002-05-08 EP disclosed
EP-1173468-A1 INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2002-01-23 EP disclosed
WO-2001010847-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2001-02-15 WO disclosed
WO-2000066618-A1 INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2000-11-09 WO disclosed